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Abstract
Background: Patients with irritable bowel syndrome (IBS) have significantly reduced quality of life (QOL). Although
intestinal and extraintestinal symptoms, as well as comorbid psychological disorders, may reduce the QOL of IBS
patients, the primary determinant of QOL in these patients remains unclear. This study aimed to identify the main
factors affecting QOL in patients with IBS with diarrhea (IBS-D).
Methods: Consecutive patients meeting the Rome III Diagnostic Criteria for IBS-D were enrolled in this study.
Patients with organic diseases were excluded. The intestinal symptoms, psychological states and QOL of these
patients were evaluated using IBS-specific symptom questionnaires, the Hamilton Depression Scale (HAMD), the
Hamilton Anxiety Scale (HAMA), and the Chinese version of the IBS-QOL instrument. Overall scores for intestinal
symptoms were calculated by frequency and degree.
Results: This study enrolled 227 IBS-D patients, of mean age 44.68 ± 10.81 years. Their mean overall IBS-QOL score
was 71.68 ± 18.54, with the lowest score being for food avoidance (53.71 ± 26.92). Overall IBS-QOL score correlated
negatively with overall scores of intestinal symptoms and HAMD and HAMA scores (p < 0.001 each). Overall intestinal
symptoms scores correlated negatively with HAMD and HAMA scores (p < 0.001 each). Scores of HAMD, HAMA and
structural factors (i.e., anxiety/somatization, cognitive disorder, psychomotor retardation, psychic anxiety, and somatic
anxiety) were significantly higher in female than in male patients (p < 0.01). Food avoidance and social reaction scores
of female patients were significantly lower than those of male patients (p < 0.05 each). The degree of defecation
urgency, frequency of passing mucus and psychomotor retardation were independent factors predicting reduced QOL
in IBS-D patients.
Conclusion: Intestinal symptoms and psychological factors jointly reduce the QOL of IBS-D patients, with gender
differences in the impact of both factors on QOL.
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Background
Irritable bowel syndrome (IBS) is characterized by ab-
dominal pain or discomfort associated with alterations
in bowel habits and stool forms. The symptoms are re-
current or persistent, which can significantly affect pa-
tients’ quality of life (QOL). QOL has been reported to
be significantly lower in IBS patients than in patients
with chronic diseases such as diabetes mellitus, hyperten-
sion, and chronic renal failure [1,2]. QOL in IBS patients
may be affected by both intestinal and extraintestinal
symptoms, as well as by comorbid psychological disorders.
Although studies have investigated the QOL status of IBS
patients, including analyzing the impact of intestinal
symptoms and/or psychological states on patients’ QOL
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The Rome III Diagnostic Criteria for Functional
Gastrointestinal Disorders classified IBS into four sub-
types: IBS with diarrhea (IBS-D), IBS with constipation
(IBS-C), mixed IBS (IBS-M) and unsubtyped (IBS-U),
with no significant differences in QOL among these four
subtypes [4]. In China, IBS-D is the most common sub-
type, with prominent clinical symptoms and a high rate
of hospital visits [7,8]. This study therefore investigated
the associations of intestinal symptoms and psycho-
logical status with QOL, as well as determining the main
factors affecting QOL in patients with IBS-D.
Methods
Subjects
This study included consecutive patients diagnosed with
IBS based on the Rome III IBS Diagnostic and Classifica-
tion Criteria between July 2009 and October 2011 and aged
18 to 70 years. Patients with organic gastrointestinal dis-
eases, connective tissue diseases and metabolic diseases
were excluded based on the results of routine blood, urine,
stool, and fecal occult blood tests; liver, kidney, and thyroid
function tests; measurements of carcinoembryonic antigen,
erythrocyte sedimentation rate, and C-reactive protein; and
abdominal ultrasound and colonoscopy, performed within
the past year. All included patients participated in the study
voluntarily and provided written informed consent. This
study was approved by the Ethics Committee of Peking
Union Medical Collage Hospital on July 7, 2009 (S-234).
Questionnaires
IBS symptom questionnaire and scoring of overall intestinal
symptoms
The questionnaire was developed based on our previous
studies of IBS epidemiology [9] and modified based on
Rome III: the Functional Gastrointestinal Disorders [10].
The questionnaire included demographic information,
main intestinal symptoms, defecation-related symptoms,
extraintestinal symptoms, psychological status, sleeping
status and diet. The questionnaires were administered by
specially trained researchers via face-to-face interviews
and were re-checked by other specialists. The main intes-
tinal symptoms and defecation-related symptoms were
scored according to frequency and degree (Table 1). The
overall score of intestinal symptoms was calculated based
on a possible score of 36. Because pre-defecation abdom-
inal pain/discomfort is the core symptom of IBS, it was
scored separately according to degree and frequency.
Simplified Chinese version of the Irritable Bowel Syndrome-
Quality of Life (IBS-QOL) questionnaire
The simplified Chinese version [11] of the IBS-QOL
questionnaire [12] was utilized. This scale has been vali-
dated and proven suitable for evaluating QOL in Chin-
ese IBS patients. This scale includes 34 items, each with
a five-point Likert-type response scale ranging from 1
(not at all) to 5 (a great deal). The individual responses
to the 34 items were summed and averaged for a total
score and then transformed to a 0-100 scale for ease of
interpretation, with higher scores indicating better IBS-
specific QOL. There are also eight domain scores, with
the total score of each also summed and transformed to
a 0-100 scale [13]. The mean overall score in healthy
Chinese subjects is 95.50 ± 6.73, with the scores on each
of the eight domains being ≥ 90.00 [11].
Hamilton Depression Scale and Hamilton Anxiety Scale
Psychological status was evaluated using the Hamilton
Depression Scale (HAMD) and the Hamilton Anxiety
Table 1 Scoring of intestinal symptoms
Scores (point) 0 1 2 3
Intestinal symptoms
Main intestinal symptoms
Frequency of pre-defecation abdominal pain/discomfort – ≥3 day/month ≥1 day/week Every day
Degree of pre-defecation abdominal pain/discomfort – Mild Moderate Severe
Frequency of bowel movement during symptom onset – ≤3/day 4-5/day ≥6/day
Stool form during symptom onset (Bristol stool form scale) – 4-5 6 7
Improvement of abdominal pain/discomfort with defecation – Complete relief Relief ≥1/2 Relief <1/2
Defecation-related symptoms
Degree of abdominal distention None Mild Moderate Severe
Degree of urgency None Mild Moderate Severe
Degree of defecation straining None Mild Moderate Severe
Frequency of passing mucus None Occasionally Sometimes Often
Degree of incomplete defecation None Mild Moderate Severe
Amount of fecal incontinence None Small Medium Large
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Scale (HAMA) [14], which were administered by two
specially trained professionals through conversation and
observation. The HAMD scale was divided into five
structural factors: anxiety/somatization, cognitive dis-
order, psychomotor retardation, sleep disorder and
weight; and the HAMA scale was divided into two struc-
tural factors: psychic anxiety and somatic anxiety.
Statistical analysis
Patient data were entered into a database established
using Epidata software version 3.02. Data were analyzed
using SPSS 18.0 software (SPSS, Chicago, IL, USA). Con-
tinuous data are reported as mean ± standard deviation
and categorical data as number (rate). Continuous vari-
ables were analyzed using ANOVA and the independent
two-sample t-test or Mann-Whitney test. Categorical
variables were compared using the chi-squared test and
the Mantel-Haenszel test. Correlation analysis was per-
formed using Spearman rank correlation analysis or




This study included 227 IBS-D patients, 133 males and
94 females (male/female ratio 1.41:1), of mean age 44.68 ±
10.81 years and the mean duration of disease 7.00 ±
7.32 years.
QOL in IBS-D patients
The overall IBS-QOL score was 71.68 ± 18.54. The low-
est score was for food avoidance (53.71 ± 26.92), the sec-
ond lowest was for dysphoria (64.98 ± 24.40) and the
highest was for body image (86.18 ± 15.67). Females had
significantly lower food avoidance (49.38 ± 26.50 vs.
56.77 ± 26.89, p = 0.037) and social reaction (76.53 ±
22.65 vs. 83.41 ± 17.94, p = 0.015) scores than males
(Table 2). Significant differences between genders were
observed on six items of the IBS-QOL questionnaire
(Table 3). In contrast, patient age, occupation, education,
labor type (manual or mental), marriage and family eco-
nomic status did not significantly affect their QOL.
The impact of intestinal symptom scores on IBS-QOL
The overall intestinal symptoms score was 15.25 ± 3.30.
There were no significant between gender differences in
overall intestinal symptoms scores, main intestinal
symptom scores and defecation-related symptom scores
(all p > 0.05). Overall IBS-QOL scores correlated negatively
with the overall intestinal symptom scores (r = -0.342,
p = 0.000), main intestinal symptom scores (r = -0.218,
p = 0.001) and defecation-related symptom score
(r = -0.314, p = 0.000).
The impact of HAMD and HAMA scores on IBS-QOL
The mean HAMD score was 13.92 ± 5.90 and the mean
HAMA score was 17.19 ± 7.37. Both HAMD score
[r1 = -0.460, p = 0.000 (Figure 1a)] and HAMA score
[r2 = -0.434, p = 0.000 (Figure 1b)] showed significant
negative correlations with overall IBS-QOL score.
Comparison of the structural factors in the scales and
overall scores of HAMD and HAMA between male and
female patients showed that female patients had higher
scores than male patients on both the HAMD and
HAMA; as well as higher scores on the structural factors
of the HAMD scale, including anxiety/somatization, cog-
nitive disorder, and psychomotor retardation; and higher
scores on the structural factors of the HAMA scale, in-
cluding somatic anxiety and psychic anxiety (p < 0.01
each; Table 4).
Relationship between intestinal symptom scores and
HAMD and HAMA scores
Linear correlations were observed between the overall
score of intestinal symptoms and the HAMD (r1 = 0.316,
p = 0.000) and HAMA (r2 = 0.303, p = 0.000) scores. In
addition, significant linear correlations were observed
between main intestinal symptom scores and HAMD
Table 2 IBS-QOL and eight domain scores in male and female IBS-D patients
Score Total (N = 227) Male (N = 133) Female (N = 94) p value*
IBS-QOL 71.68 ± 18.54 73.76 ± 17.29 68.73 ± 19.89 0.076
Dysphoria 64.98 ± 24.40 66.71 ± 23.23 62.53 ± 25.90 0.275
Interference with activity 67.94 ± 23.79 70.62 ± 21.68 64.13 ± 26.13 0.105
Body image 86.18 ± 15.67 88.25 ± 13.61 83.24 ± 17.85 0.076
Health worry 67.40 ± 22.71 68.48 ± 22.34 65.87 ± 23.25 0.427
Food avoidance 53.71 ± 26.92 56.77 ± 26.89 49.38 ± 26.50 0.037†
Social reaction 80.56 ± 20.27 83.41 ± 17.94 76.53 ± 22.65 0.015†
Sexual 83.09 ± 25.22 83.65 ± 24.96 82.31 ± 25.69 0.706
Relationship 81.75 ± 20.46 83.39 ± 19.07 79.43 ± 22.19 0.232
*Males vs. females; †p < 0.05.
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(r1 = 0.214, p = 0.000) and HAMA (r2 = 0.191, p = 0.004)
scores, as well as between defecation-related symptom
scores and HAMD (r1 = 0.285, p = 0.000) and HAMA
(r2 = 0.280, p = 0.000) scores.
The impact of intestinal symptoms, depression and
anxiety on the IBS-QOL
The collinearity of 18 items, including 11 intestinal
symptom scores, five structural factor scores of the
HAMD scale, and two structural factor scores of the
HAMA scale was analyzed. Five independent factors were
identified, including the frequency of pre-defecation ab-
dominal pain/discomfort, degree of urgency, frequency of
passing mucus, psychomotor retardation and somatic anx-
iety. Multiple linear regression analysis showed that the
degree of defecation urgency, frequency of passing mucus
and psychomotor retardation were independent predictors
of decreased IBS-QOL (Table 5). When independent pre-
dictors were calculated separately for male and female
patients, we found that the degree of urgency, fre-
quency of passing mucus, somatic anxiety and psycho-
motor retardation were independent predictors of a low
overall IBS-QOL score for male patients; whereas psy-
chomotor retardation was the only independent pre-
dictor of low overall IBS-QOL score for female patients
(Table 6).
Discussion
Being specific for IBS, the IBS-QOL scale has been
widely used in clinical practice [4,15-17] and has been
shown suitable for evaluating the severity of IBS and
assessing treatment outcomes in clinical practice [17].
The present study found that overall IBS-QOL scores
were generally lower in IBS-D patients, with food avoid-
ance scores being the lowest. This result is in accordance
with the results of other studies evaluating IBS patients
[3,4,8,13,17-19]. Epidemiological studies in both Asian
[7,20-22] and Western [23-26] patients have shown that
the prevalence of IBS was higher in females than in
males. In addition, female patients were reported to have
lower IBS-QOL scores than males [15,27]. In the present
study, 58.6% of the patients were males, suggesting that
males may be more likely to have IBS-D whereas females
are more likely to have IBS-C [28,29], or that the rate of
hospital visits may be higher among Chinese males than
females with IBS-D. Although overall IBS-QOL scores
were similar in males and females, food avoidance and
social reaction scores were lower in females, similar to
previous findings [3,16]. The significantly lower food
avoidance scores in female IBS-D patients were due
mainly to their response to the statement, “I have to
watch the amount of food I eat because of my bowel
problems.” This suggests that female IBS-D patients are
more likely to regard a certain type of improper food as
Table 3 Significant between gender differences on six items of the IBS-QOL questionnaire
Item Male (N = 133) Female (N = 94) p value*
Q2 I am embarrassed by the smell caused by my bowel problems 81.39 ± 21.81 72.87 ± 30.16 0.029
Q17 I worry that people think I exaggerate my bowel problems 84.21 ± 26.29 75.00 ± 31.75 0.018
Q21 My bowel problems limit what I call wear 92.67 ± 19.65 78.72 ± 32.78 0.000
Q22 I have to avoid strenuous activity because of my bowel problems 81.95 ± 25.44 73.40 ± 32.13 0.026
Q27 Long trips are difficult for me because of my bowel problems 68.61 ± 33.28 55.05 ± 37.13 0.004
Q28 I feel frustrated that I cannot eat when I want because of my bowel problems 65.98 ± 31.73 57.18 ± 34.71 0.049
*Males vs. females.
Figure 1 Correlation between overall IBS-QOL scores and scores on the (a) HAMD and (b) HAMA. Overall IBS- QOL scores were significantly
negatively correlated with HAMD (r1 = -0.460, p = 0.000) and HAMA (r2 = -0.434, p = 0.000) scores.
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the main cause of their intestinal symptoms and want to
relieve their symptoms by avoiding that type of food. In
contrast, male IBS patients are reported to have different
IBS-related types and quantities of food than females
[30]. The social reaction scores were significantly lower
for female than male IBS-D patients, as indicated by
their replies to the statements: “I am embarrassed by the
smell caused by my bowel problems” and “I worry that
people think I exaggerate my bowel problems”, to which
female patients responded more affirmatively. In
addition, female IBS-D patients were more likely to re-
gard their bowel problems as limiting the clothing they
could wear (item 21) and to want to avoid strenuous
activity (item 22) and long trips (item 27). All of these
responses indicate that the social reactions of female
IBS-D patients are affected by their intestinal symptoms.
Although gender-related traits have been associated with
IBS-QOL, it is unclear whether these traits or their
linked psychosocial disorders affected patients’ responses
to their intestinal symptoms [15].
Studies of the impact of age, type of work, occupation,
education, marriage and family economic status on the
QOL of IBS patients have yielded different results
[7,21,31-33]. A study in Egypt showed that people with
low education and income levels and those performing
manual labor were more likely to suffer from IBS than
educated professionals [34]. In contrast, this study found
that QOL in Chinese patients with IBS-D was not af-
fected by age, education, occupation, type of work,
marriage or family economic status, consistent with
findings in Iran [4].
Korean studies [3,5] showed that the overall score of
intestinal symptoms and the severity described by the
patient were independent factors affecting health-related
QOL (HRQOL) scores of IBS patients, and that pre-
defecation abdominal pain/discomfort significantly af-
fected patients’ QOL [3,35,36]. In the present study,
overall IBS-QOL scores of IBS-D patients were signifi-
cantly correlated with overall scores of intestinal symp-
toms. Further analysis showed that the main intestinal
symptoms, including the frequency and degree of pre-
defecation abdominal pain/discomfort, increased num-
bers of bowel movements and loose/watery stools at
symptom onset, and improvements in abdominal pain/
discomfort following defecation, did not significantly
affect the QOL of patients with IBS-D. Although no sin-
gle symptom significantly affected the QOL of IBS-D pa-
tients, a significant negative correlation was observed
between their main intestinal symptom scores and over-
all IBS-QOL scores, indicating that the integrated sever-
ity of intestinal symptom may reduce patients’ QOL.
Defecation urgency and passing mucus were the most
common IBS-associated symptoms in the present study,
with both being independent risk factors affecting QOL.
We did not determine the mechanism by which urgency
and passing mucus affected patients’ QOL. In clinical
practice, patients usually state that urgency limited their
travel activities, even for taking a bus to working sites.
Table 4 Comparison of HAMD, HAMA and structural factors scores between male and female IBS-D patients
Score Total (N = 227) Male (N = 133) Female (N = 94) p value*
HAMD 13.92 ± 5.90 12.75 ± 5.24 15.56 ± 6.40 0.000†
Anxiety /somatization 7.49 ± 2.75 6.98 ± 2.56 8.23 ± 2.85 0.001†
Cognitive disorder 1.57 ± 1.34 1.35 ± 1.61 1.86 ± 1.49 0.005†
Psychomotor retardation 2.61 ± 1.87 2.35 ± 1.61 2.98 ± 2.13 0.012†
Sleep disorder 2.14 ± 1.80 1.96 ± 1.68 2.38 ± 1.95 0.083
Body weight 0.11 ± 0.34 0.11 ± 0.33 0.11 ± 0.34 0.980
HAMA 17.19 ± 7.37 15.53 ± 6.38 19.54 ± 8.05 0.000†
Somatic anxiety 8.64 ± 4.14 7.82 ± 3.62 9.79 ± 4.54 0.000†
Psychic anxiety 8.55 ± 3.95 7.71 ± 3.61 9.74 ± 4.12 0.000†
*Males vs. females; †p < 0.05.
Table 5 Factors independently predictive of poorer quality of life in IBS-D patients
Items Regression p value Partial correlation
coefficient (β) Coefficient p value
Constants 91.573 0.000
Degree of xurgency -2.725 0.006 -0.157 0.019 R2 = 0.270
Frequency of passing mucus -2.412 0.015 -0.146 0.029
Psychomotor retardation -4.327 0.000 -0.298 0.000
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Most people in China use public transportation, with
few sites on these routes having toilets. The effect of
passing mucus on QOL may be related to patients’ lack
of medical knowledge and paying too much attention to
passing mucus. Urgency and passing mucus contributed
to the decreased overall IBS-QOL score in male patients
and had a greater effect on total QOL scores of male
than of female IBS-D patients.
Psychological factors are also associated with the
pathogenesis of IBS, since they can affect intestinal func-
tion via the autonomic nervous system and brain-gut
axis [37,38]. It has been estimated that 50% to 90% of
IBS patients have psychological disorders [38,39], pri-
marily depression and anxiety, although neuroses and
hypochondria have also been reported. These comorbid
psychological disorders may affect patients’ QOL
[3,6,13,40], and psychological treatment may improve
their QOL [11,41]. Evaluation using the Hospital Anxiety
and Depression Scale (HAD) showed that IBS patients
with anxiety and depression often had more serious in-
testinal symptoms and that their QOL was compromised
significantly [5,42]. However, few studies have analyzed
the structural factors linking the HAD and HAMA/
HAMD scales with patients’ QOL. One study found that
eight factors independently predicted mental HRQOL,
including feeling tense, nervous, and hopeless; difficulty
sleeping; tiring easily; low sexual interest; IBS symptom
interference with sexual function; and low energy [40].
Results of the present study showed that overall IBS-
QOL scores correlated negatively with HAMD and
HAMA scores, and that psychomotor retardation on the
HAMD scale was able to predict patients’ QOL inde-
pendently. This factor on the HAMD scale includes
depressed mood (dysphoria), work and interests, psycho-
motor retardation status and sexual function (loss of li-
bido). Depressed mood and loss of interest are core
symptoms in depressive disorders. Depressed patients
with psychomotor retardation may require intensive care
to ensure adequate food and fluid intake and sufficient
personal care. Our results indicate the need to recognize
psychomotor retardation and to apply appropriate inter-
vention to improve QOL.
HAMD scores, including scores on its structural fac-
tors anxiety/somatization, cognitive disorder, and psy-
chomotor retardation, and HAMA scores, including
scores of its two structural factors, somatic anxiety and
psychic anxiety, were significantly higher in female than
in male patients with IBS-D, suggest that the associated
psychological disorders were more significant in female
patients. Only the psychomotor retardation score, an ac-
knowledged characteristic of depression, significantly af-
fected patients’ QOL. However, somatic anxiety was an
independent predictor of QOL in male patients.
The associations between intestinal symptoms and/or
the psychological state of IBS patients and their QOL
have been verified [5,6,36,43]. Psychological distress is
less dependent on gastrointestinal symptom severity in
patients with IBS than in those with inflammatory bowel
diseases; in the latter, psychological distress has a greater
direct effect on HRQOL than gastrointestinal symptoms
[6]. Results of the present study showed that the intes-
tinal symptom scores of IBS-D patients were positively
correlated with HAMD/HAMA scores, but that both
were negatively correlated with patients’ IBS-QOL scores,
suggesting an interactive network linking intestinal symp-
toms, QOL, and psychological state. These findings sug-
gest that the frequent onset or continuous presence of
intestinal symptoms (represented by high intestinal symp-
tom score) can aggravate patients’ psychological burden,
and that comorbid psychological disorders may aggravate
patients’ subjective feelings about their intestinal and som-
atic symptoms, resulting in multiple extraintestinal symp-
toms. This may lead patients to excessively avoid foods
and disproportionately worry about their intestinal symp-
toms, reducing their outside activities and, in turn, their
QOL. This cycle suggests that the reduced QOL in IBS-D
patients results from the combined impact of intestinal
symptoms and psychological abnormalities.
Table 6 Factors independently predictive of reduced quality of life in male and female IBS-D patients
Items Regression
coefficient (β)




Degree of urgency -2.733 0.022 -0.181 0.041 R2 = 0.264
Frequency of passing mucus -2.947 0.014 -0.207 0.019
Psychomotor retardation -2.860 0.005 -0.226 0.010
Somatic anxiety -0.927 0.039 -0.199 0.024
Female
Constants 82.910 0.000
Psychomotor retardation -4.759 0.000 -0.376 0.000 R2 = 0.252
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This study had several limitations. First, since our hos-
pital is a referral center for patients in China with diffi-
cult and complicated diseases, most of the patients
enrolled in this study had moderate to severe illness.
Second, the IBS symptom questionnaire and the intes-
tinal symptom scoring method have not been validated.
Finally, the severity and frequency of intestinal and
defecation-related symptoms were reported by patients
themselves. However, nociceptive contributions, the de-
gree of disability, culture, psychological distress and poor
HRQOL may influence patients’ report of the severity of
their symptoms [35].
Conclusions
The combination of intestinal symptoms and comorbid
psychological factors in patients with IBS-D affects their
QOL, with the impact of both differing by gender. In fe-
male patients, comorbid psychological disorders are
more significant, and the effects of food avoidance and
social reactions are more obvious. Therefore, it is rec-
ommended that intestinal and defecation-related symp-
toms be controlled promptly in male patients and that
psychological interventions be applied to female patients
with obvious anxiety and/or depression.
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